Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Antimicrobial Agents and Chemotherapy|February 20, 2014
Robust and persistent replication of the genotype 6a hepatitis C virus replicon in cell cultureMei Yu, Betty Peng, Katie Chan, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2010
Novel hepatitis C virus reporter replicon cell lines enable efficient antiviral screening against genotype 1aMargaret Robinson, Huiling Yang, Siu-Chi Sun, et al.
Gastroenterology|September 25, 2012
Development of robust hepatitis C virus genotype 4 subgenomic repliconsBetty Peng, Mei Yu, Simin Xu, et al.
Journal of Biomolecular Screening|February 8, 2011
Optimized high-throughput screen for hepatitis C virus translation inhibitorsKatherine E Berry, Betty Peng, David Koditek, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2016
In Vitro Antiviral Activity and Resistance Profile Characterization of the Hepatitis C Virus NS5A Inhibitor LedipasvirGuofeng Cheng, Yang Tian, Brian Doehle, et al.
Antimicrobial Agents and Chemotherapy|August 14, 2013
Preclinical characterization of the novel hepatitis C virus NS3 protease inhibitor GS-9451Huiling Yang, Margaret Robinson, Amoreena C Corsa, et al.
Antimicrobial Agents and Chemotherapy|July 13, 2011
Mechanistic characterization of GS-9190 (Tegobuvir), a novel nonnucleoside inhibitor of hepatitis C virus NS5B polymeraseI-Hung Shih, Inge Vliegen, Betty Peng, et al.
Antimicrobial Agents and Chemotherapy|January 15, 2014
Inhibition of hepatitis C virus replication by GS-6620, a potent C-nucleoside monophosphate prodrugJoy Y Feng, Guofeng Cheng, Jason Perry, et al.
Pageof 1